Skip to search formSkip to main contentSkip to account menu

Non-Biologic Disease-Modifying Antirheumatic Drug

Known as: Non-Biologic DMARD 
A drug used to alter the progression of autoimmune disease that is not a biologic.
National Institutes of Health

Related topics

Related topics

1 relation
Antirheumatic Drugs, Disease-Modifying

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study
AbstractIntroductionPatients with rheumatoid arthritis (RA) who are treated with adalimumab (ADA) are offered a proprietary… 
Review
2016
Review
2016
Assessment of the Therapeutic Effect of Total Glucosides of Peony for Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children; some clinical trials have reported the… 
2014
2014
SAT0076 Effectiveness of RA BIOLOGICS in the Two Years following Initiation Using A Validated Claims-Based Algorithm
Background Biologic disease modifying antirheumatic drugs (DMARD) are a mainstay of Rheumatoid Arthritis (RA) treatment. A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)